NCT00588172View on ClinicalTrials.gov

Genetic Variation in OCT1 and Response to Metformin

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2011

Conditions
Type 2 Diabetes
Interventions
DRUG

Metformin

1000mg bid for 1 week

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER